Funding Rounds
MISSION Therapeutics

MISSION Therapeutics Series A (2011, $6M)

MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →